CHARY LOPEZ-PEDRERA

Has grant

Head of Research

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Chary Lopez-Pedrera is the Head of Research at IMIBIC/Reina Sofia Hospital/University of Cordoba, Spain. His research focuses on the molecular mechanisms of autoimmune diseases, particularly in rheumatoid arthritis and antiphospholipid syndrome. Recent publications include studies on transcriptome signatures predicting treatment responses and insights into the relationship between cytokines and disease progression. He is involved in advancing precision medicine approaches in addressing complex health conditions.

Recent Grants

Grant: Close

New therapeutic targets, drug repositioning and identification of translational biomarkers in autoimmune diseases using multi-omics analysis and artificial intelligence. multi-omics analysis and artificial intelligence.

Open Date: 2022-01-01

Close Date: 2024-12-01

Grant: Close

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions Innovative Medicine Initiative (3-TR)

Open Date: 2019-01-01

Close Date: 2026-01-01

Grant: Close

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases Mechanisms for the Improvement of Drug Development and Therapy. PRECISESADS

Open Date: 2014-01-01

Close Date: 2019-01-01

Grant: Close

Characterization of Baricitinib effects on the pro-thrombotic and cardiovascular risk profile of Rheumatoid Arthritis patients

Open Date:

Close Date:

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (16)

Antonio Fernandez-Nebro

Profesor titular acreditado como catedrático (Reader)

University of Malaga

SPAIN

CHARY LOPEZ-PEDRERA

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis?

Predictors of Mortality in Antiphospholipid Antibody–Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository (“Registry”)

DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case–control study

Identification of a novel transcriptome signature for predicting the response to anti-TNF-α treatment in patients with rheumatoid arthritis.

Molecular insights into the relationship between sustained CRP elevation and endothelial dysfunction in axial spondyloarthritis.

Towards precision medicine in antiphospholipid syndrome.

Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs

Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants.

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis

Sex-specific metabolic adaptations in transgenic mice overexpressing cytochrome b5 reductase-3

Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and <scp>InternatiOnal</scp> Networking Clinical Database and Repository

Preclinical Characterization of Pharmacologic <scp>NAD</scp><sup>+</sup> Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis

The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis

Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets

Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features

Editorial: Clinical management, pathogenesis and biomarkers of cardiovascular disease associated with systemic autoimmune disorders

Collaborators (16)

Antonio Fernandez-Nebro

Rebeca Perez de Diego

Jose Cordoba-Chacon

Pilar Font Ugalde

Fernando Leiva-Cepas

Savino Sciascia

José Pardos-Gea

Laura ANDREOLI

Paloma Vela Casasempere

Manuel D. Gahete

Eva Perez-Pampin

Cecilia Chighizola

Hannah Cohen

Paul R. Fortin

Howard Belmont

Vittorio Pengo

Make your next move.